Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

6 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Early oral switch to combined cefixime therapy for management of osteoarticular infections in pediatric sickle cell disease patients: A descriptive analysis.
Mohzari YA, Alshuraim R, Asdaq SMB, Aljobair F, Alrashed A, Alsowaida YS, Alamer A, Al Munjem MF, Al Musawa MI, Hatata M, Alzaaqi MA, Binrokan A, Alajlan SA, Abraham I, Alamer A. Mohzari YA, et al. Among authors: al musawa mi. J Infect Public Health. 2022 Jan;15(1):1-6. doi: 10.1016/j.jiph.2021.11.006. Epub 2021 Nov 17. J Infect Public Health. 2022. PMID: 34852307 Free article.
Tocilizumab effectiveness in mechanically ventilated COVID-19 patients (T-MVC-19 Study): a multicenter real-world evidence.
Mohzari YA, Alamer A, Alattas M, Alrashed AA, Alshehab NA, Alkhaldi TK, Alamer AA, Asdaq SMB, Aljefri D, Alajami HN, Alsowaida YS, Mathew M, AlMusawa MI, Alomar M, Alharbi RY, Khuwaja M, Bamogaddam RF, Alharthi AH, Faqihi AY, Alrumayyan BF, Alshareef A, Alhassan BM, Damfu NY, Alajmi GS, Albujaidy A, Alghalbi M, Alajlan SA, Abraham I, Almulhim AS. Mohzari YA, et al. Expert Rev Anti Infect Ther. 2022 Jul;20(7):1037-1047. doi: 10.1080/14787210.2022.2046462. Epub 2022 Mar 7. Expert Rev Anti Infect Ther. 2022. PMID: 35209783 Free PMC article.
Ceftolozane-tazobactam vs. colistin for the treatment of infections due to multidrug-resistant Pseudomonas aeruginosa: a multicentre cohort study.
Almangour TA, Aljabri A, Al Musawa M, Almohaizeie A, Almuhisen S, Damfu N, Alfozan A, Alraddadi BM, Alattas M, Qutub M, Alhameed AF, Khuwaja M, Alghamdi A, Binkhamis KM, Alfahad W, AlShahrani FS. Almangour TA, et al. J Glob Antimicrob Resist. 2022 Mar;28:288-294. doi: 10.1016/j.jgar.2022.01.023. Epub 2022 Feb 1. J Glob Antimicrob Resist. 2022. PMID: 35121161 Free article.
Effectiveness of traditional non-carbapenem β-lactams vs. novel β-lactams for the treatment of carbapenem-resistant Pseudomonas aeruginosa: a retrospective cohort study.
Aldardeer NF, Labban HM, Alhuthil RT, Aljahdali SH, Alharbi MH, Alharbi RA, Al Musawa MI, Almalki AA, Almangour TA. Aldardeer NF, et al. Among authors: al musawa mi. BMC Infect Dis. 2024 Dec 22;24(1):1455. doi: 10.1186/s12879-024-10365-5. BMC Infect Dis. 2024. PMID: 39710682 Free PMC article.